Canadian Pharmaceuticals & Biotech Most Popular Stocks

Cytophage Technologies

Market Cap: CA$15.1m

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

Sharp Therapeutics

Market Cap: CA$15.0m

A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.

Lobe Sciences

Market Cap: CA$14.5m

A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.

Marvel Biosciences

Market Cap: CA$13.5m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

SOL Global Investments

Market Cap: CA$12.6m

A private equity firm specializing in emerging growth.

Pharmala Biotech Holdings

Market Cap: CA$12.3m

Pharmala Biotech Holdings Inc., doing business as PharmAla, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Nextleaf Solutions

Market Cap: CA$11.8m

A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.

COSCIENS Biopharma

Market Cap: CA$11.6m

A life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally.

Medicure

Market Cap: CA$11.5m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Avant Brands

Market Cap: CA$10.3m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Christina Lake Cannabis

Market Cap: CA$9.9m

A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.

Innovotech

Market Cap: CA$9.8m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Khiron Life Sciences

Market Cap: CA$9.3m

Operates as an integrated medical and cannabis company in Latin America and Europe.

Crescita Therapeutics

Market Cap: CA$9.0m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

Glow Lifetech

Market Cap: CA$8.6m

A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.

PharmaCielo

Market Cap: CA$8.5m

Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.

Kane Biotech

Market Cap: CA$8.3m

A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.

Rakovina Therapeutics

Market Cap: CA$8.1m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

Ayurcann Holdings

Market Cap: CA$7.8m

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

Quest PharmaTech

Market Cap: CA$7.6m

A pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer.

Blueberries Medical

Market Cap: CA$7.4m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

BioVaxys Technology

Market Cap: CA$7.3m

A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.

Mountain Valley MD Holdings

Market Cap: CA$7.0m

A biotech company, focused on advancing solutions to optimize human, animal, and plant health in Canada.

Delivra Health Brands

Market Cap: CA$7.0m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

Sweet Earth Holdings

Market Cap: CA$6.6m

Does not have significant operations.

Revive Therapeutics

Market Cap: CA$6.6m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

Herbal Dispatch

Market Cap: CA$6.5m

Owns and operates cannabis e-commerce platforms in Canada and the United States.

Telo Genomics

Market Cap: CA$6.5m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

XORTX Therapeutics

Market Cap: CA$5.6m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

CanadaBis Capital

Market Cap: CA$5.5m

Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.

MYND Life Sciences

Market Cap: CA$5.2m

A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

1933 Industries

Market Cap: CA$5.0m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

4Front Ventures

Market Cap: CA$4.6m

Engages in cultivating, processing, manufacturing, and sale of cannabis products in the United States.

Aptose Biosciences

Market Cap: CA$4.2m

A clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States.